Business Wire

Biomind Labs Inc. Completes Reverse Take-Over Transaction

Common Shares Expected to Commence Trading on the Neo Exchange on or about July 28, 2021 Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in o

More

Cybin Announces Conditional Listing Approval from NYSE American

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received conditional listing approval from the NYSE Amer

More